haloperidol has been researched along with Corneal Opacity in 1 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Corneal Opacity: Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakaya-Onishi, M | 1 |
Kiritoshi, A | 1 |
Hasegawa, T | 1 |
Watanabe, H | 1 |
Shimomura, Y | 1 |
Tano, Y | 1 |
1 other study available for haloperidol and Corneal Opacity
Article | Year |
---|---|
Corneal endothelial cell loss after excimer laser keratectomy, associated with tranquilizers.
Topics: Benzodiazepines; Cell Count; Cell Size; Cornea; Corneal Opacity; Corneal Stroma; Endothelium, Cornea | 1996 |